A Study of the Efficacy and Safety of Topiramate in the Prevention of Migraine

PHASE3CompletedINTERVENTIONAL

Enrollment

768

Participants

Timeline

Start Date

March 31, 2001

Study Completion Date

November 30, 2002

Conditions

MigraineCommon MigraineClassic MigraineHeadache

Interventions

DRUG

topiramate

All Listed Sponsors

lead

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

INDUSTRY

NCT00231595 - A Study of the Efficacy and Safety of Topiramate in the Prevention of Migraine | Biotech Hunter | Biotech Hunter